Abemaciclib combined with endocrine therapy for the adjuvant treatment of HR 1+, HER2 2–, node-positive, high-risk, early breast cancer (monarchE)abstract - Johnston, SRD; Harbeck, N; Hegg, R (J Clin Oncol, 2020)
et al.